Lucintel Forecasts Gene Expression Market To Grow At A Cagr Of 7%-9% From 2020 To 2025

By Author: Lucintel LLC
Total Articles: 7501
Comment this article

According to the recent study the gene expression market is projected to grow at a CAGR of 7%-9% from 2020 to 2025. Growth in this market is primarily driven by decreasing cost of sequencing, technological advancements, rising prevalence of cancer, availability of government funding, novel technologies to aid gene expression studies, growing application areas of gene expression, and availability of gene expression databases.
Browse XX figures / charts and XX tables in this 150 -page report to understand trends, opportunities and forecast in gene expression market by product and service (consumables (kits and reagents and DNA chips), instruments (PCR, NGS, DNA microarray, and others), and services (gene expression profiling services (sequencing services and other services) and bioinformatics solutions), process (sample collection, purification, cDNA synthesis & conversion, PCR analysis, and data analysis & interpretation), capacity (low- to mid- plex and high-plex), technique (RNA expression (northern blotting, DNA microarrays, PCR techniques, and RNA-seq), promoter analysis (in vitro transcription/nuclear ...
... run-on assays, gel shift assays, and chromatin immunoprecipitation (ChIP)), and protein expression & posttranslational modification analysis (western blotting, 2-D gel electrophoresis, immunoassays, and mass spectrometry), application (drug discovery & development, clinical diagnostics, biotechnology & microbiology, and others), end user (pharmaceutical and biotech companies, academic institutes and research centers, and others), and region (North America, Europe, Asia Pacific, and Rest of the World).
Download sample report and view detailed Table of Content by clicking on below link https://www.lucintel.com/gene-expression-market.aspx

“Kits and reagents market is expected to remain the largest segment during the forecast period.”
Based on product and service, the gene expression market is segmented into kits and reagents and DNA chips. Lucintel forecasts that the kits and reagents market is expected to remain the largest segment due to the higher usage of these products, low price, launch of novel kits and reagents with enhanced efficiency, and rising demand for better data interpretation & visualization.
“Within the gene expression market, the pharmaceutical and biotechnology companies segment is expected to remain the largest end user”
Based on end user,the pharmaceutical and biotechnology companies segment is expected to witness the highest growth over the forecast period due to the utilization of gene expression analysis products and services to achieve clinical research goals, increasing focus on developing targeted therapies, and increasing in the demand for gene expression analysis services offered by CROs.
“North America will dominate the gene expression market in near future”
North America will remain the largest region, and it is also expected to witness the highest growth over the forecast period due to the presence of a substantial number of well-established players in the region, increased focus on advanced healthcare, government support to initiatives that promote precision medicines, and high investments in genomic research.
Download Brochure of this report by clicking on https://www.lucintel.com/gene-expression-market.aspx
Major players of gene expression market are adopting various growth strategies like new product launches, expansions, merger and acquisitions, partnerships, agreements, and collaborations to expand their presence in this market. Illumina, Thermo Fisher Scientific, Bio-Rad Laboratories, F. Hoffmann-La Roche, GE Healthcare, Pacific Biosciences of California, Agilent Technologies, QIAGEN, Oxford Gene Technologies, and Eurofins Scientific are among the major gene expression providers.
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link https://www.lucintel.com/gene-expression-market.aspxor helpdesk@lucintel.com
About Lucintel
At Lucintel, we offer solutions for you growth through game changer ideas and robust market &unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times. For further information, visit www.lucintel.com

Contact:
Brandon Fitzgerald
Lucintel
Dallas, Texas, USA
Email: brandon.fitzgerald@lucintel.com
Tel. 972.636.5056
Cell: 303.775.0751
Related reports
Minimally Invasive Surgical Instrument Market:
For more details click here https://www.lucintel.com/minimally-invasive-surgical-instrument-market.aspx

Endoscopy Equipment Market:
For more details click here https://www.lucintel.com/endoscopy-equipment-market.aspx

Surgical Instrument Tracking System Market:
For more details click here https://www.lucintel.com/surgical-instrument-tracking-system-market.aspx

Metabolomics Market:
For more details click here https://www.lucintel.com/metabolomics-market.aspx

Industrial Microbiology Market:
For more details click here https://www.lucintel.com/industrial-microbiology-market.aspx

Surgical Microscope Market:
For more details click here https://www.lucintel.com/surgical-microscope-market.aspx

Tumor Ablation Market:
For more details click here https://www.lucintel.com/tumor-ablation-market.aspx

Vitamin D Market:
For more details click here https://www.lucintel.com/vitamin-d-market.aspx

Urology Device Market:
For more details click here https://www.lucintel.com/urology-device-market.aspx

GMO Testing Market:
For more details click here https://www.lucintel.com/gmo-testing-market.aspx